GRAd-COV2

GRAd-COV2 Uses, Dosage, Side Effects, Food Interaction and all others data.

GRAd-COV2 is a COVID-19 vaccine candidate being developed by ReiThera. This therapy is based on a novel replication-incompetent simian adenoviral vector that encodes the full-length SARS-CoV-2 spike protein (GRAd-COV2). Preclinical and clinical studies show GRAd-COV2 to induce robust cellular and humoral immune responses.

Trade Name GRAd-COV2
Generic GRAd-COV2
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
GRAd-COV2
GRAd-COV2

Innovators Monograph

You find simplified version here GRAd-COV2


*** Taking medicines without doctor's advice can cause long-term problems.
Share